Introduction {#S1}
============

The Wolffian duct (WD) is a primordium of the male reproductive tract, which develops into the epididymis, vas deferens, and seminal vesicles. In addition, the WD plays a crucial role in kidney development as the primordium for the ureter and kidney collecting duct system ([@R8]; [@R62]). In mouse embryos, the WD is formed in the anterior intermediate mesoderm at embryonic (E) day 8.5 (E8.5), elongating caudally to reach the cloaca by E9.5 ([@R2]; [@R17]). WD insertion into the cloaca has been reported to be essential for ureter positioning ([@R15]; [@R75]). Three successive kidneys develop along the WD in an anterior--posterior manner: the pronephros, mesonephros, and metanephros ([@R13]). The pronephros is formed at the most anterior level of the WD at E8.5, and degenerates by E9.5 ([@R20]). The mesonephros is subsequently formed posterior to the pronephros. The cranial part of the mesonephric mesenchyme differentiates into the mesonephric tubules (MTs) ([@R20]). Degeneration of the mesonephric mesenchyme begins from caudal at E10.5 and extends cranially ([@R33]). At the same time, in the caudal end of the mesonephros, the WD develops a multilayered, "pseudostratified epithelia", forming the ureteric bud (UB) ([@R14]). The metanephros, which is the definitive kidney in mammals, begins to form from the UB and adjacent metanephric mesenchyme (MM) ([@R78]). Malformation of the WD in the caudal mesonephros, in addition to the UB, often results in the congenital anomalies in human, such as duplex ureter and absence of the vas deferens. The characterization of the nephrogenic regions, especially the caudal mesonephros, has just started to be understood for their susceptibility to such developmental abnormality ([@R33]; [@R49]; [@R51]).

The reciprocal interaction between the WD epithelia and adjacent nephrogenic mesenchyme is essential for the morphogenesis of all kidney structures ([@R5]). In such interactions, growth factor signaling, including Glial cell line-derived neurotrophic factor (Gdnf), Wnt, and Fibroblast growth factor (Fgf), are well characterized signaling pathways. Dysregulation of these signaling pathways often causes ectopic UB formation, mostly in the caudal part of the mesonephros ([@R3]; [@R10]; [@R28]; [@R38]; [@R42]; [@R45]; [@R51]; [@R66]).

Receptor tyrosine kinase (RTK) signaling is a key requirement for the development of many organs. It regulates cellular processes including proliferation, survival, differentiation, and migration ([@R63]). Binding of ligands to their RTKs activates several intracellular pathways such as phosphoinositide 3-kinase (PI3K)/AKT, mitogen-activated protein kinase (MAPK), and phospholipase C-gamma (PLC-gamma) ([@R69]). Several RTKs such as Rearranged during transfection (RET) and Fgf receptor (FGFR) play an essential role in vertebrae embryonic development, especially in mammalian kidney development ([@R4]; [@R7]; [@R16]; [@R46]; [@R58]; [@R60]; [@R61]; [@R64]).

There are four FGFRs that interact with 18 known FGF ligands in mammals ([@R6]; [@R52]). The expression of *Fgfr1* and *Fgfr2* is detected in the metanephros and in the cranial part of the mesonephros ([@R12]; [@R22]; [@R36]; [@R54]; [@R57]; [@R59]; [@R81]). In contrast, *Fgfr3* and *Fgfr4* are not detected in the mesonephros ([@R36]). Conditional knockout (KO) approaches in mice have revealed that *Fgfr1* and *Fgfr2* in the kidney mesenchyme are crucial for early MM formation and UB induction ([@R29]; [@R59]; [@R74]). On the other hand, epithelial FGFR signaling regulates the branching morphogenesis of the metanephric kidney, possessing minor functions on initial UB formation ([@R81]). Recent studies indicate that FGFR signaling may compensate loss of GDNF/RET signaling, which is the most essential RTK signaling for the ureteric budding ([@R40]; [@R44]; [@R72]). Although the functions of FGF signaling in metanephric kidney morphogenesis have been analyzed, its function in WD development has not been well described. In addition, the possible compensation between different RTKs in the WD has not been investigated.

In this study, we examined the roles of FGFR signaling in the WD using mouse genetic models. WD-specific inactivation of *Fgfr2* revealed a developmental region-specific function for FGFR2 on regulation of cell proliferation.

Materials and methods {#S2}
=====================

Mice {#S3}
----

The mouse strains used herein were *Fgfr1^flox^* ([@R82]), *Fgfr2^flox^* ([@R79]), *Hoxb7-Cre* ([@R77]), *ROSA26-LacZ* ([@R70]), *ROSA26-YFP* ([@R71]), *Ret-GFP* ([@R25]) and ICR (CLEA, Tokyo, Japan). *Hoxb7-Cre* mice and *ROSA26-YFP* mice were obtained from Jackson Laboratory. *Fgfr2*-null alleles were generated by crossing *Fgfr2^flox^* mice to *CAGGS-Cre* mice ([@R1]), which express Cre recombinase in the germline. All experimental procedures and protocols were approved by the Animal Research Committee of the Wakayama Medical University and Kumamoto University. Embryos for each experiment were collected from at least three pregnant females. Noon on the day when a vaginal plug was detected was designated as E0.5. Embryos used for analyses at E10.5 were not identified their gender. Male embryos were used for the analyses at E12.5 and later.

Histology and immunohistochemistry {#S4}
----------------------------------

Tissues were fixed in 4% paraformaldehyde, dehydrated, embedded in paraffin, and sectioned. Hematoxylin and eosin (HE) staining was performed by standard procedures as previously described ([@R30]). For immunohistochemistry, deparaffinized sections were treated for antigen retrieval (autoclave 121 °C for 1 min in 10 mM citrate buffer at pH 6.0) and incubated with 3% H~2~O~2~ in methanol for 10 min to inactivate endogenous peroxidase before 1 h incubation with a blocking solution (1.5% fetal bovine serum (FBS) in PBS). Anti-cleaved caspase-3 polyclonal antibody (Cell Signaling Technology, Danvers, MA, 1:1000), anti-ZO-1 polyclonal antibody (Invitrogen, Carlsbad, CA, 1:200), anti-laminin polyclonal antibody (Sigma-Aldrich, St. Louis, MO, 1:100), or anti-E-cadherin monoclonal antibody (BD Biosciences, San Jose, CA, 1:400) in PBS solution was added to the slides and incubated for 1 h at room temperature. Negative controls were obtained by excluding the primary antibodies. After washing with PBS, the sections were stained with the Vectastain ABC Kit (Vector Laboratories, Burlingame, CA) or incubated with Alexa 546/488-labeled goat anti-rabbit/mouse IgG (Life Technologies, Grand Island, NY) or horseradish peroxidase-labeled rabbit anti-goat IgG (Zymed, South San Francisco, CA) for 1 h at room temperature. Where indicated, the sections were subsequently incubated with 3, 3-diaminobenzidine tetrahydrochloride (DAB) containing H~2~O~2~. Sections were counterstained by Hoechst 33342 (Sigma-Aldrich), Hematoxylin (Wako, Osaka, Japan), or Methyl Green (Sigma-Aldrich).

Cell proliferation assay {#S5}
------------------------

Pregnant females were injected intraperitoneally with 25 mg 5-ethynyl-2′-deoxyuridine (EdU; Invitrogen) per 1 kg body weight. One hour after injection, embryos were collected. Embryos were fixed and processed for paraffin-embedding as described above. Serial horizontal sections (6 μm/section) were made from the cranial end to the caudal end of the WD. EdU-labeled cells were stained using the Click-iT EdU Alexa Fluor 555 Imaging Kit (Invitrogen) according to the supplier's instructions. The total cell number (stained by Hoechst) and the total number of EdU-positive cells were counted for each epithelial portion. The percentage proliferation was calculated as the fraction of EdU-positive cells over the total number of nuclei. Statistical analysis was performed using the Mann--Whitney test (*P*\<0.05 was considered significant).

Whole-mount and section RNA in situ hybridization for gene expression {#S6}
---------------------------------------------------------------------

Whole-mount and section *in situ* hybridization was performed using digoxigenin-labeled probes as previously described ([@R30]). Probes for the following genes were used: *Pax2* ([@R21]), *Fgfr1* (kindly provided by Dr. J. Partanen), *Fgfr2* ([@R55]), *Etv4* (provided by Dr. D. M. Ornitz), *Etv5* (provided by Dr. D. M. Ornitz), *Ret* ([@R50]), *Gdnf* ([@R50]), and *Fgf10* (kindly provided by Dr. H. Ohuchi and Dr. N. Itoh). For the confirmation of the *Fgfr2* mutation, a probe that does not recognize the mutated allele was used ([@R79]).

Results {#S7}
=======

Fgfr2 is the major Fgfr gene expressed in the WD epithelia {#S8}
----------------------------------------------------------

Although *Fgfr* expression has been partially reported, their expression in the mesonephros has been poorly described. To identify patterns of *Fgfr* expression in the WD, whole-mount RNA *in situ* hybridization was performed at E10.5. *Fgfr1* and *Fgfr2* were expressed throughout the mesonephros of wild-type embryos at E10.5 ([Fig. 1A and E](#F1){ref-type="fig"}, arrow). *Fgfr1* expression was more prominent in the MTs ([Fig. 1A and B](#F1){ref-type="fig"}, arrowheads) and mesenchyme ([Fig. 1B--D](#F1){ref-type="fig"}) than that in the epithelia of the WD ([Fig. 1B--D](#F1){ref-type="fig"}, dashed line, indicated in [Fig. 1I](#F1){ref-type="fig"}). In contrast, *Fgfr2* expression was more prominent in the epithelia of the WD ([Fig. 1F--H](#F1){ref-type="fig"}, dashed line, indicated in [Fig. 1I](#F1){ref-type="fig"}) compared to the MTs ([Fig. 1E and F](#F1){ref-type="fig"}, arrowheads) and mesenchyme ([Fig. 1F--H](#F1){ref-type="fig"}). *Fgfr2* expression was also observed in the WD epithelia locating near the cloaca ([Fig. 1J](#F1){ref-type="fig"}, dashed line).

WD-specific inactivation of Fgfr2 results in WD regression in the caudal mesonephros {#S9}
------------------------------------------------------------------------------------

*Cre* activity driven by the *Hoxb7* promoter was analyzed by crossing *Hoxb7-Cre* mice with the *ROSA26-LacZ* reporter strain and embryos were analyzed for β-galactosidase (βgal) enzyme activity. βgal-positive cells were located throughout the WD epithelia in *Hoxb7-Cre; ROSA26^LacZ/+^* embryos at E10.5 and E9.5 ([Supplemental Fig. S1A--C](#SD1){ref-type="supplementary-material"}) ([@R37]; [@R47]; [@R77]). Most of the epithelial cells were βgal-positive in the WD, and a few βgal-negative cells were observed in the cranial part ([Supplemental Fig. S1A](#SD1){ref-type="supplementary-material"}, arrow). A small number of βgal-positive cells were observed in MTs ([Supplemental Fig. S1A](#SD1){ref-type="supplementary-material"}, arrowhead). The percentage of βgal-positive cells in each region of the WD epithelia of *Hoxb7-Cre; ROSA26^LacZ/+^* embryos at E10.5 was shown in [Supplemental Fig. S1](#SD1){ref-type="supplementary-material"} (*n*=3).

To examine the roles of FGFR2 signaling during WD development, *Hoxb7-Cre; Fgfr2*^+/−^ male mice were crossed with *Fgfr1^flox/flox^*; *Fgfr2^flox/flox^* female mice to get *Hoxb7-Cre; Fgfr1^flox/+^*; *Fgfr2^flox/−^* embryos. Hereafter, we refer to *Hoxb7-Cre; Fgfr1^flox/+^*; *Fgfr2^flox/−^* mice as WD-specific *Fgfr2*-inactivation mice (*Fgfr2^WD\ flox/−^*). Control mice are either heterozygous for the *Fgfr2* floxed allele (*Hoxb7-Cre; Fgfr1^flox/+^*; *Fgfr2^flox/+^*) or lack the *Hoxb7-Cre* transgenic allele.

Inactivation of *Fgfr2* in the WD of *Fgfr2^WD\ flox/−^* embryos was confirmed by whole-mount RNA *in situ* hybridization. *Fgfr2* was expressed in the WD and MTs in the control embryos at E10.5, while its expression was reduced in *Fgfr2^WD\ flox/−^* embryos compared to the controls at E10.5 ([Fig. 2A and A′](#F2){ref-type="fig"}, black arrow and arrowheads). To examine the development of WD structure in *Fgfr2^WD\ flox/−^* mice, whole-mount RNA *in situ* hybridization for *Pax2* was performed. *Pax2* expression was observed in the WD, MTs, and condensed mesenchyme in both control and *Fgfr2^WD\ flox/−^* embryos at E10.5 ([Fig. 2B and B′](#F2){ref-type="fig"}, black arrow, black arrowheads, and white arrowheads). The MTs were formed along the cranial WD ([Fig. 2B and B′](#F2){ref-type="fig"}, black arrowheads) and the UB invaginated dorsally ([Fig. 2B and B′](#F2){ref-type="fig"}, yellow arrow), showing no significant differences between the control and *Fgfr2^WD\ flox/−^* embryos. Histological analysis showed a well-established epithelial structure in the cranial part of the WD in both control and *Fgfr2^WD\ flox/−^* embryos at E10.5 ([Fig. 2E and E′](#F2){ref-type="fig"}, black arrow, indicated in [Fig. 2S](#F2){ref-type="fig"}). In the caudal part, no significant differences were observed in the size of the WD between the control and some *Fgfr2^WD\ flox/−^* embryos (3 out of total 7 samples), whereas a hypoplastic WD of the caudal mesonephros was observed in other *Fgfr2^WD\ flox/−^* embryos (4 out of total 7 samples; [Fig. 2F and F′](#F2){ref-type="fig"}, black arrow, also indicated in [Fig. 2S](#F2){ref-type="fig"}). The ductal epithelia reached the cloacal epithelia in both control and *Fgfr2^WD\ flox/−^* embryos at E10.5 (7 out of total 7 samples; [Fig. 2L and L′](#F2){ref-type="fig"}, black arrowheads). The well-differentiated pseudostratified epithelia of the UB were detected even in *Fgfr2^WD\ flox/−^* embryos with hypoplastic WD of the caudal mesonephros ([Fig. 2G and G′](#F2){ref-type="fig"}, also indicated in [Fig. 2S](#F2){ref-type="fig"}). These data indicate that the WD is formed in the mutant embryos by E10.5. At E12.5, the WD marked by *Pax2* expression was observed from cranial to caudal of the control embryos ([Fig. 2C](#F2){ref-type="fig"}). In contrast, such *Pax2* expression was disrupted in the WD of the caudal mesonephros of *Fgfr2^WD\ flox/−^* embryos ([Fig. 2C′](#F2){ref-type="fig"}, red arrow). Histological analysis revealed that the cranial epithelial structure was indistinguishable between the control and *Fgfr2^WD\ flox/−^* WD ([Fig. 2H and H′](#F2){ref-type="fig"}, indicated in [Fig. 2T](#F2){ref-type="fig"}). In contrast, the WD of the caudal mesonephros showed regressing epithelia in *Fgfr2^WD\ flox/−^* embryos (a red arrow in [Fig. 2I′](#F2){ref-type="fig"}, also indicated in [Fig. 2T](#F2){ref-type="fig"}; 8 out of total 10 samples in [Table 1](#T1){ref-type="table"}). Taken together, these results suggest that epithelial FGFR signaling is essential for the maintenance of the WD, especially in the caudal mesonephros. At E16.5, the control embryos possessed well-differentiated WD derivatives, the epididymis and vas deferens, connected to the urogenital sinus ([Fig. 2D](#F2){ref-type="fig"}). *Fgfr2^WD\ flox/−^* embryos, on the other hand, showed a dilation of the duct in the cranial WD ([Fig. 2D, D′, J, and J′](#F2){ref-type="fig"}, indicated in [Fig. 2U](#F2){ref-type="fig"}; 4 out of total 6 samples in [Table 1](#T1){ref-type="table"}), and the epithelial structure was not observed in the vas deferens derived from the WD of the caudal mesonephros ([Fig. 2K and K′](#F2){ref-type="fig"}, also indicated in [Fig. 2U](#F2){ref-type="fig"}).

Functional redundancy of *Fgfr1* and *Fgfr2* has been reported in several developmental systems ([@R31]; [@R56]; [@R76]). To examine the function of *Fgfr1* upon inactivation of *Fgfr2* in the WD epithelia, *Hoxb7-Cre; Fgfr1^flox/−^*; *Fgfr2^flox/−^* (*Fgfr1/2^WD\ flox/−^*) mice were investigated. *Fgfr1/2^WD\ flox/−^* embryos showed regressing epithelia in the WD of the caudal mesonephros at E12.5 ([Fig. 2N](#F2){ref-type="fig"}, red arrow; 3 out of total 3 samples in [Table 1](#T1){ref-type="table"}), as observed in *Fgfr2^WD\ flox/−^* embryos ([Fig. 2I′](#F2){ref-type="fig"}; 8 out of total 10 samples in [Table 1](#T1){ref-type="table"}). In contrast, the epithelial structure was indistinguishable in the cranial part between the control and *Fgfr1/2^WD\ flox/−^* WDs ([Fig. 2H and M](#F2){ref-type="fig"}). At E16.5, the gross morphology of *Fgfr1/2^WD\ flox/−^* embryos showed dilated duct formation in the cranial part, with an obstructed duct in the caudal part at E16.5 ([Fig. 2O](#F2){ref-type="fig"}; 2 out of total 3 samples in [Table 1](#T1){ref-type="table"}), as observed in *Fgfr2*^WD\ flox/−^ embryos ([Fig. 2D′](#F2){ref-type="fig"}; 4 out of total 6 samples in [Table 1](#T1){ref-type="table"}). By the histological analysis of the *Fgfr1/2^WD\ flox/−^* WD, the presence of epithelia in the cranial part was observed, while the epithelial structure was not evident in the caudal part (data not shown), as observed in *Fgfr2^WD\ flox/−^* embryos ([Fig. 2J′ and K′](#F2){ref-type="fig"}). *Hoxb7-Cre; Fgfr1^flox/−^*; *Fgfr2^flox/+^ (Fgfr1^WD\ fl^*^ox/−^) embryos showed no obvious phenotypes; well-differentiated WDs reached the urogenital sinus as well as the control WD at E16.5 ([Fig. 2R](#F2){ref-type="fig"}, *n* = 4 in [Table 1](#T1){ref-type="table"}) and at E12.5 ([Fig. 2P and Q](#F2){ref-type="fig"}; *n*=8 in [Table 1](#T1){ref-type="table"}). This is consistent with the absence of prominent *Fgfr1* expression in the WD epithelia during WD development ([Fig. 1B--D](#F1){ref-type="fig"}). These results indicate that *Fgfr2* is the dominant FGF receptor for the maintenance of the WD in the caudal mesonephros, and *Fgfr1* may contribute with a small amount of redundancy.

Decreased expression of the downstream target genes of RTK signaling in the WD epithelia of Fgfr2^WD\ flox/−^ embryos {#S10}
---------------------------------------------------------------------------------------------------------------------

*Etv4* and *Etv5* are downstream targets of RTK signaling including FGFR ([@R9]; [@R27]; [@R39]). The expression pattern of *Etv4* and *Etv5* in the WD was examined at the WD of the cranial and caudal mesonephros, and UB ([Fig. 3N](#F3){ref-type="fig"}). Both *Etv4* and *Etv5* were expressed in the WD epithelia, MT, and condensed nephrogenic mesenchyme of E10.5 control embryos (dashed line, black arrowhead, and white arrowhead in [Fig. 3A--C and D--F](#F3){ref-type="fig"}). Expression of these genes was reduced in the WD epithelia of the cranial and caudal mesonephros of *Fgfr2^WD\ flox/−^* embryos, compared to control embryos ([Fig. 3A, A′, B, B′, D, D′, E and E′](#F3){ref-type="fig"}, dashed line). The expression of these genes was not significantly different in the MTs ([Fig. 3A, A′, D, and D′](#F3){ref-type="fig"}, black arrowhead) and the condensed mesenchyme ([Fig. 3B, B′, E, and E′](#F3){ref-type="fig"}, white arrowhead) between the control and *Fgfr2^WD\ flox/−^* embryos. Notably, the expression of *Etv4* and *Etv5* in the epithelia adjacent to the MM (MM side) was retained at the UB level, whereas it was decreased in the epithelia at the opposite side of the MM (coelom side) in *Fgfr2^WD\ flox/−^* embryos ([Fig. 3C, C′, F, and F′](#F3){ref-type="fig"}, red arrowheads, indicated in [Fig. 3O](#F3){ref-type="fig"}).

In addition to FGFR signaling, GDNF/RET signaling is also essential RTK signaling for UB formation ([@R11]; [@R24]; [@R46]; [@R58]; [@R61]; [@R64]). Failure of UB formation is the most frequent phenotype associated with *Gdnf* or *Ret* deficiency ([@R16]). In control embryos, *Ret* was expressed throughout the WD epithelia ([Fig. 3G--I](#F3){ref-type="fig"}, dashed line; [Fig. 3J](#F3){ref-type="fig"}, black arrow), with the highest level of expression in the UB at E10.5 ([Fig. 3I](#F3){ref-type="fig"}, dashed line; [Fig. 3J](#F3){ref-type="fig"}, yellow arrow). In contrast, Ret expression was reduced in the WD of the cranial and caudal mesonephros, and in the coelom side of the UB of *Fgfr2^WD\ flox/−^* embryos ([Fig. 3G--I and G′--H′](#F3){ref-type="fig"}, dashed line, red arrowheads; [Fig. 3J and J′](#F3){ref-type="fig"}, black arrow). Ret expression in the MM side of the UB was not affected in *Fgfr2^WD\ flox/−^* embryos at E10.5 ([Fig. 3I′](#F3){ref-type="fig"}, dashed line; [Fig. 3J′](#F3){ref-type="fig"}, yellow arrow). These results suggest that *Ret* expression may be regulated by *Fgfr2* in the WD epithelia, except in the MM side of the UB. This observation is consistent with the finding that UB outgrowth was unaffected in *Fgfr2^WD\ flox/−^* embryos until E13.5 (data not shown) ([@R81]).

In the WD, it is reported that chimeric expression of *Ret* in the UB results in epithelial cell rearrangement to exclude the *Ret*-negative cells from the MM side of the UB ([@R14]). To trace the lineage of cells in which Cre was activated in the *Fgfr2^WD\ flox/−^* background, we crossed *Hoxb7-Cre; Fgfr2*^+/−^ mice with *Fgfr2^flox/flox^*; *ROSA26^YFP/YFP^* mice to obtain *Hoxb7-Cre; ROSA26^YFP/+^*; *Fgfr2^flox/−^* embryos. Recombined cells, marked by GFP, were distributed throughout the WD and displayed no significant differences when compared with *Hoxb7-Cre; ROSA26^LacZ/+^* embryos at E10.5 ([Supplemental Figs. S1 and S2](#SD1){ref-type="supplementary-material"}). Uniform distribution of the recombined cells in the UB was observed in *Fgfr2^WD\ flox/−^* embryos ([Supplemental Fig. S2](#SD1){ref-type="supplementary-material"}). These results suggest that *Hoxb7-Cre*-mediated *Fgfr2* gene recombination in the WD was introduced ubiquitously and recombined cell-specific epithelial cell rearrangement may not occur in the *Fgfr2^WD\ flox/−^* WDs. Taken together, these results suggest that FGFR2 signaling is the major RTK signaling pathway in the WD epithelia, but not in the MM side of the UB, at E10.5.

To examine the involvement of GDNF/RET signaling in *Etv* expression in the WD, we analyzed Ret KO mice at E10.5. *Ret* gene mutations lead to renal agenesis and hypoplasia, and ectopic ureter termination ([@R18]; [@R25]; [@R34]; [@R65]). Sustained expression of *Etv4* and *Etv5* was observed in all regions of the WD epithelia of *Ret* KO embryos (dashed line in [Fig. 3K--M and K′--M′](#F3){ref-type="fig"}, data not shown). However, reduced phospho-Erk expression was observed in the MM side of the UB of *Ret* KO embryos at E10.5 (data not shown), which agrees with the previous finding ([@R14]). These results suggest that the reduced expression of *Etv4* and *Etv5* observed in *Fgfr2^WD\ flox/−^* embryos is independent of RET-mediated RTK signaling.

FGFR signaling regulates cell proliferation in the WD of the caudal mesonephros and the coelom side of the UB {#S11}
-------------------------------------------------------------------------------------------------------------

To identify the mechanism leading to the regression of the WD of the caudal mesonephros in *Fgfr2^WD\ flox/−^* embryos, cell proliferation was assessed by EdU incorporation at the WD of the cranial and caudal mesonephros, and UB at E10.5 ([Fig. 4A--C and A′--C′](#F4){ref-type="fig"}; indicated in [Fig. 4N](#F4){ref-type="fig"}). In control embryos, the WD of the caudal mesonephros and the UB displayed higher rate of cell proliferation than the cranial part ([Fig. 4A--C](#F4){ref-type="fig"}). The WD of the caudal mesonephros in the *Fgfr2^WD\ flox/−^* embryos demonstrated significantly reduced epithelial cell proliferation, compared to the control embryos ([Fig. 4B, B′, and M](#F4){ref-type="fig"}). There were no significant differences in cell proliferation in the cranial part and in the MM side of the UB between the control and *Fgfr2^WD\ flox/−^* WDs ([Fig. 4A, A′, C, C′ and M](#F4){ref-type="fig"}). Fewer proliferating cell nuclei were observed in the coelom side of the UB in *Fgfr2^WD\ flox/−^* embryos than in the control embryos ([Fig. 4C, C′, and M](#F4){ref-type="fig"}). Apoptosis, indicated by cleaved caspase-3 expression, was also analyzed in control and *Fgfr2^WD\ flox/−^* embryos. No significant differences in apoptosis were observed between the control and *Fgfr2^WD\ flox/−^* embryos at E10.5 ([Fig. 4D--F and D′--F′](#F4){ref-type="fig"}, red arrowheads). These results indicate that FGFR signaling regulates cell proliferation in the WD of the caudal mesonephros and in the coelom side of the UB.

To investigate whether loss of epithelial cell polarity contributes to the epithelial regression observed in *Fgfr2^WD\ flox/−^* WDs, expression patterns of ZO-1 ([Fig. 4G--I and G′--I′](#F4){ref-type="fig"}), E-cadherin, and laminin ([Fig. 4J--L and J′--L′](#F4){ref-type="fig"}) was analyzed. The core tight junction protein, ZO-1, was detected at the apical side of epithelial cells in both control and *Fgfr2^WD\ flox/−^* WDs ([Fig. 4G--I and G′--I′](#F4){ref-type="fig"}). E-cadherin, an adherence junction protein, and laminin, a basement membrane component, were detected at the apical and lateral side of the cells and at the basement membrane, respectively, in *Fgfr2^WD\ flox/−^* WDs as well as in control embryos ([Fig. 4J--L and J′--L′](#F4){ref-type="fig"}). These results suggest that polarized epithelia are established and maintained in *Fgfr2^WD\ flox/−^* WDs.

Region-specific expression of RTK ligands in the mesonephros and metanephros {#S12}
----------------------------------------------------------------------------

FGF7 and FGF10 are ligands with high specificity for the FGFR2-IIIb isoform ([@R53]; [@R80]). Previous studies have demonstrated that *Fgf7* is not detected in the developing kidney before E14.5 ([@R26]; [@R41]). On the other hand, FGF10 is considered the main ligand for FGFR in the WD ([@R19]).

*Fgf10* expression was observed in both the MM and the mesenchyme of the coelom side with a pattern showing a higher expression at the UB level that gradually decreases as it proceeds cranially ([Fig. 5A and B](#F5){ref-type="fig"}, [Supplemental Fig. S4](#SD1){ref-type="supplementary-material"}). *Gdnf*, a ligand for RET signaling, was expressed mainly in the MM of the control embryos ([Fig. 5C and D](#F5){ref-type="fig"}). Localization of *Fgf10* and *Gdnf* expression in the *Fgfr2^WD\ flox/−^* embryos was essentially similar to that in the control embryos ([Fig. 5A--D and A′--D′](#F5){ref-type="fig"}).

Discussion {#S13}
==========

WD as a model for ductal formation and its abnormalities {#S14}
--------------------------------------------------------

The current study demonstrates that FGFR2 signaling prevents WD regression in the caudal mesonephros, and that loss of FGFR2 in the WD may lead to dilation of the cranial part of the WD. A previous study using FGF10 null mice reported cystic dilation in the epididymis and degeneration of the vas deferens ([@R19]). However, the corresponding mechanisms were not identified. In the current study, we demonstrated that reduced FGF signaling in the WD epithelia results in WD regression in the caudal mesonephros. Luminal fluid from the testis to the WD is essential for further development of the WD into male reproductive tract ([@R32]; [@R67]; [@R73]). Since fluid secretion commences at approximately E13--14 in mice ([@R35]), the obstruction of the WD in the caudal mesonephros in *Fgfr2^WD\ flox/−^* embryos may cause accumulation of the fluid, leading to dilation of the cranial part of the WD at E16.5.

Formation of the common nephric duct (CND), the WD which locates caudally to the UB, was observed in both the control and *Fgfr2^WD\ flox/−^* embryos at E12.5 ([Supplemental Fig. S3A and A′](#SD1){ref-type="supplementary-material"}). At E14.5, the CND was eliminated, and the WD and ureter were separated in the control and *Fgfr2^WD\ flox/−^* embryos ([Supplemental Fig. S3B, B′, C, and C′](#SD1){ref-type="supplementary-material"}; the level of B and B′ is more anterior than that of C and C′). Our observation that the WD and the ureter were inserted into the urogenital sinus separately at E14.5 suggests that the dilation of the cranial epididymal duct was a consequence of the obstruction of the duct, not of back-flow of urine. Another potential mechanism underlying such dilation might be the disruption of oriented cell division, as described previously in the kidney of *Fgfr1* and *Fgfr2* double mutant mice ([@R68]).

The WD also grows craniocaudally after reaching the cloaca. Immunohistochemical analysis for ZO-1, E-cadherin, and laminin expressions indicated that the epithelial cells maintained their characteristics in *Fgfr2^WD\ flox/−^* WDs at E10.5. Cell proliferation is considered to be the major contributor for WD elongation, and the WD of the caudal mesonephros is the most mitotically active in the WD ([Fig. 4A--C](#F4){ref-type="fig"}) ([@R23]; [@R35]; [@R43]). Considering that apoptosis was not increased in *Fgfr2^WD\ flox/−^* WDs compared to control WDs at E10.5, it is possible that decreased cell proliferation in the WD of the caudal mesonephros causes the ductal thinning observed in *Fgfr2^WD\ flox/−^* embryos at E12.5 and later. The current study suggests that active cell proliferation regulated by FGFR signaling in the WD of the caudal mesonephros is essential to maintain the ductal size and epithelial integrity in the growing duct at a later stage.

RTK signaling via FGFR is required for WD development {#S15}
-----------------------------------------------------

The current study demonstrates that WD epithelial cell proliferation is regulated by distinct region-specific FGFR signaling.

The frequency of βgal-negative cells in the cranial WD epithelia of *Hoxb7-Cre; ROSA26^LacZ/+^* embryos was higher than that in the WD of the caudal mesonephros and UB. It is possible that the sustained epithelial cell proliferation in the cranial part of mutant WDs might be due to lower activity of *Hoxb7-Cre* in the cranial WD epithelia. However, significant reduction of active RTK signaling, indicated by *Etv4* and *Etv5* expression, was observed in the cranial part of *Fgfr2^WD\ flox/−^* WDs compared to control WDs. These results suggest that RTK signaling is sufficiently reduced in the cranial part of *Fgfr2^WD\ flox/−^* WDs. Taken together, RTK signaling through *Etv4* and *Etv5* may possess less contribution to epithelial cell proliferation in the cranial WD. *Fgf8* is expressed in MTs at E10.5 and its mesoderm-specific conditional KO mice display degeneration in the cranial part of the WD and missing cranial MTs ([@R36]). Moreover, mesoderm-specific conditional KO mice for *Fgfr1* and *Fgfr2* show loss of the WD and MTs ([@R36]). These observations may suggest that FGFR signaling in MTs or in the nephrogenic mesenchyme is essential for the maintenance of the cranial part of the WD.

In *Fgfr2^WD\ flox/−^* embryos, epithelial cell proliferation in the MM side of the UB did not show any significant reduction. The expression pattern of Ret, *Etv4*, and *Etv5* in *Fgfr2^WD\ flox/−^* embryos indicated that RTK signaling via RET was retained in the MM side of the UB. These results are consistent with the previous findings that UB outgrowth is regulated mainly by GDNF/RET signaling ([@R46]; [@R58]; [@R60]; [@R61]; [@R64]). In *Ret* KO mice, almost 40% of embryos show ureteric budding, and additional inhibition of FGFR signaling completely abolishes UB formation ([@R44]; [@R64]). These previous observations indicate partial redundancy between RET and FGFR signaling in the UB.

The current work demonstrated that *Ret* expression was reduced in the WD epithelia, except in the MM side of the UB in *Fgfr2^WD\ flox/−^* embryos, suggesting that *Fgfr2* probably regulates GDNF/RET signaling in the WD of the caudal mesonephros and the coelom side of the UB. However, analysis of *Ret* KO embryos suggests that GDNF/RET signaling is dispensable for *Etv* expression and also for cell proliferation (data not shown) in these parts. These results indicate that RTK signaling via FGFR is required for WD development.

To our knowledge, *Fgf10* is the only RTK ligand that is distinctly expressed in the mesenchyme of the caudal mesonephros and of the coelom side of the UB at E10.5. In contrast, *Gdnf* is prominently expressed in the metanephric mesenchyme. This region-specific expression pattern of RTK ligands may explain the region-specific FGFR2 dependency of RTK signaling in the WD epithelia, *i.e*., the possible redundancy of RTK signaling between FGF and GDNF in the MM side of the UB but not in the coelom side and the WD of the caudal mesonephros.

In conclusion, the current study demonstrates that WD epithelial cell proliferation is regulated by distinct region-specific mechanisms during its development. The results suggest that FGFR signaling is essential for cell proliferation of the WD in the caudal mesonephros and the coelom side of the UB. The WD is fundamental not only for the development of the transient or definitive kidneys but also for the development of the reproductive tract. The WD is also essential for the formation of the Mullerian duct (MD), female reproductive tract anlarge. The MD extends from cranial to caudal under the guidance of the WD around E12.5 ([@R48]). Therefore, it is possible that the abnormality observed in the current mutant embryos may also consequently affect the MD development and female reproductive tract development. Further analyses regarding female embryos may provide broad function of FGF signaling in reproductive tract formation. The current study provides novel insights into the regulation of urogenital tract development, including male and female reproductive tract, and kidney.
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![*Fgfr2* is the major *Fgfr* gene expressed in the WD epithelia. Whole-mount RNA *in situ* hybridization to detect *Fgfr1* (A) and *Fgfr2* (E) expression in the mesonephros of wild-type embryos was performed at E10.5. Section RNA *in situ* hybridization to detect *Fgfr1* (B--D) and *Fgfr2* (F--H, and J) expression in the mesonephros of wild-type embryos was performed at E10.5. For the histological analyses of horizontal sections at E10.5, the WD is divided into three parts along the axis by the following definition: (1) cranial part, the WD where MTs are present; (2) caudal part, the WD of the caudal mesonephros (the WD between the cranial part and the UB); and (3) UB part, the WD where the pseudostratified epithelia is observed. A schematic representation of the cranial (B and F), caudal (C and G), and UB (D and H) parts in the WD at E10.5 are presented in I. *Fgfr2* expression in the portion that lies near the cloaca is shown in J. Scale bars: A and E, 500 μm; B--D, F--H, and J, 50 μm. Arrow, WD; arrowheads, MTs; dashed line, WD epithelia; Cl, cloaca.](nihms668372f1){#F1}

![WD-specific inactivation of *Fgfr2* results in WD regression in the caudal mesonephros. Whole-mount RNA *in situ* hybridization to detect *Fgfr2* expression in the WD and MTs of the control (A) and *Fgfr2^WD\ flox/−^* (A′) embryos was performed at E10.5. Insets show high magnification views of the caudal mesonephros (A and A′). The WD and MTs are marked by *Pax2* expression in the control (B and C) and *Fgfr2^WD\ flox/−^* (B′ and C′) embryos at E10.5 (B and B′) and E12.5 (C and C′). Insets show high magnification views of the caudal mesonephros (B, B′, Cand C′). The gross morphology of the WD and testis at E16.5 is shown inD (control) and D′ (*Fgfr2^WD\ flox/−^*). HE staining of the WD in the control (E--L) and *Fgfr2^WD\ flox/−^* (E′--L′) embryos was performed at E10.5 (E--G, L, E′--G′, and L′), E12.5 (H, I, H′, and I′), and E16.5 (J, K, J′, and K′). Schematic representations indicating the axial levels of the WD at E10.5, E12.5, and E16.5 are presented in S, T, and U. The WD that lies near the cloaca is shown in L (Control) and L′ (*Fgfr2^WD\ flox/−^*). HE staining at E12.5 and the gross morphology of the WD and testis at E16.5 in *Fgfr1/2^WD\ flox/−^* and *Fgfr1^WD\ flox/−^* embryos are shown in M--O and P--R. Scale bars: A--C and A′--C′, 100 μm; D, D′, O, and R, 500 μm; E--N, P, Q, and E′--L′, 50 μm. Black arrow, WD; black arrowheads, MTs; white arrowheads, condensed mesenchyme; yellow arrow, UB; red arrow, regression of WD epithelia; Cl, cloaca; t, testis.](nihms668372f2){#F2}

![Decreased expression of the downstream target genes of RTK signaling in the WD epithelia *of Fgfr2^WD\ flox/−^* embryos. Section RNA *in situ* hybridization for *Etv4* (A--C and A′--C′), *Etv5* (D--F and D′--F′), and *Ret* (G--I and G′--I′) in E10.5 embryos in the cranial (A, A′, D, D′, G, and G′), caudal (B, B′, E, E′, H, and H′), and UB (C, C′, F, F′, I, and I′) parts was performed in the control (A--I) and *Fgfr2^WD\ flox/−^* (A′--I′) embryos. Whole-mount RNA *in situ* hybridization to detect *Ret* expression was performed in the control (J) and *Fg*f*r2^WD\ flox/−^* (J′) embryos at E10.5. Section RNA *in situ* hybridization for *Etv5* in wild-type (K--M) and *Ret* KO (K′--M′) embryos for the cranial (K and K′), caudal (L and L′), and UB (M and M′) parts was performed at E10.5. A schematic representation of the cranial, caudal, and UB parts in the WD at E10.5 is shown in N. A schematic representation of the MM and coelom sides of the UB at E10.5 is shown in O. Scale bars: A--I, K--M, A′--I′, and K′--M′, 50 μm; J and J′, 100 μm. Dashed line, WD epithelia; black arrowhead, MT; white arrowhead, condensed mesenchyme; MM, metanephric mesenchyme; red arrows, coelom side of the UB; yellow arrow, UB.](nihms668372f3){#F3}

![FGFR signaling regulates cell proliferation in the WD of the caudal mesonephros and the coelom side of the UB. Proliferative cells were labeled with EdU (red) and co-stained with E-cadherin (green) at the cranial (A and A′), caudal (B and B′), and UB (C and C′) parts in the control (A--C) and *Fgfr2^WD\ flox/−^* (A′--C′) embryos. Nuclei were stained with Hoechst 33342. Immunohistochemistry for cleaved caspase-3 demonstrated the presence of apoptotic cells at the axial levels of the cranial (D and D′), caudal (E and E′), and UB (F and F′) parts in the control (D--F) and *Fgfr2^WD\ flox/−^* embryos (D′--F′). Sections were counterstained with hematoxylin. Immunohistochemistry for ZO-1 was performed at the axial levels of the cranial (G and G′), caudal (H and H′), and UB (I and I′) parts in the control (G--I) and *Fgfr2^WD\ flox/−^* (G′--I′) embryos. Sections were counterstained with methyl green. Immunofluorescence staining of laminin (red) and E-cadherin (green) in sections of E10.5 WD was performed at the axial levels of the cranial (J and J′), caudal (K and K′), and UB (L and L′) parts in the control (J--L) and *Fgfr2^WD\ flox/−^* (J′--L′) embryos. Nuclei were stained with Hoechst 33342. The graph (M) demonstrated the rate of EdU-positive cells per total cells in the WD epithelia in the control and *Fgfr2^WD\ flox/−^* embryos. A schematic representation of the cranial, caudal, and UB parts in the WD at E10.5 is presented in N. The UB is divided into two domains, the MM side and coelom side, as indicated in O. Scale bars: 50 μm. Red arrowheads, signals of cleaved caspase-3; dashed line, WD epithelia; MM, metanephric mesenchyme.\
\*\**P*\< 0.01; n = 4 per genotype (cranial and caudal), n = 6 per genotype (UB); values are mean + SD.](nihms668372f4){#F4}

![Region-specific distribution of RTK ligands in the mesonephros and metanephros. Section RNA *in situ* hybridization for *Fgf10* (A, A′, B, and B′) and *Gdnf* (C, C′, D, and D′) in the caudal mesonephros (A, A′, C, and C′) and UB (B, B′, D, and D′) was performed in the control (A--D) and *Fgfr2^WD\ flox/−^* (A′--D′) embryos at E10.5. Scale bars: 50 μm. Dashed line, WD epithelia; MM, metanephric mesenchyme.](nihms668372f5){#F5}

###### 

Phenotypic incidence of *Fgfr2^WD\ flox/−^*, *Fgfr1/2^WD\ flox/−^* and *Fgfr*1*^WD\ flox/−^* embryos.

  Individual allele with genotype                                       E12.5   E16.5
  --------------------------------------------------------------------- ------- -------
  *Hoxb7-Cre; Fgfr*1*^flox/+^; Fgfr2^flox/−^ (Fgfr2^WD\ flox/−^*)       8/10    4/6
  *Hoxb7-Cre; Fgfr1^flox/−^*; *Fgfr2^flox−^ (Fgfr1/2^WD\ flox/−^*)      3/3     2/3
  *Hoxb7-Cre; Fgfr1^flox/−^*; *Fgfr2*^fl^*^ox/+^ (Fgfr1^WD\ flox/−^*)   0/8     0/4

[^1]: These authors contributed equally to this work.
